{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T06:57:24Z","timestamp":1787986644005,"version":"build-2784847793"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["T32 HL134616"],"award-info":[{"award-number":["T32 HL134616"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01 NS124681"],"award-info":[{"award-number":["R01 NS124681"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine and Metabolic Science"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.endmts.2025.100266","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T16:00:55Z","timestamp":1753977655000},"page":"100266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Mineralocorticoid receptor antagonists reduce inflammatory signaling independent of myofiber mineralocorticoid receptor"],"prefix":"10.1016","volume":"19","author":[{"given":"Jeovanna","family":"Lowe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arden B.","family":"Piepho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetan K.","family":"Gomatam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peyton","family":"Debell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan N.","family":"Ballinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill A.","family":"Rafael-Fortney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.endmts.2025.100266_bb0005","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000480652","article-title":"The role of the mineralocorticoid receptor in inflammation: focus on kidney and vasculature","volume":"46","author":"Belden","year":"2017","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.endmts.2025.100266_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155944","article-title":"Effect of the IL-1 receptor antagonist Kineret\u00ae on disease phenotype in mdx mice","volume":"11","author":"Benny Klimek","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.endmts.2025.100266_bb0015","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1096\/fj.15-276782","article-title":"Mineralocorticoid receptors are present in skeletal muscle and represent a potential therapeutic target","volume":"29","author":"Chadwick","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.endmts.2025.100266_bb0020","first-page":"5167","article-title":"Myeloid cells are capable of synthesizing aldosterone to exacerbate damage in muscular dystrophy","volume":"25","author":"Chadwick","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.endmts.2025.100266_bb0025","doi-asserted-by":"crossref","first-page":"C155","DOI":"10.1152\/ajpcell.00269.2016","article-title":"Renin-angiotensin-aldosterone system inhibitors improve membrane stability and change gene-expression profiles in dystrophic skeletal muscles","volume":"312","author":"Chadwick","year":"2017","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.endmts.2025.100266_bb0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.gene.2013.08.047","article-title":"Aldosterone stimulates fibronectin synthesis in renal fibroblasts through mineralocorticoid receptor-dependent and independent mechanisms","volume":"531","author":"Chen","year":"2013","journal-title":"Gene"},{"issue":"Suppl. 2","key":"10.1016\/j.endmts.2025.100266_bb0035","doi-asserted-by":"crossref","first-page":"S397","DOI":"10.1086\/374754","article-title":"TREM-1 (triggering receptor expressed on myeloid cells): a new player in acute inflammatory responses","volume":"187","author":"Colonna","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.endmts.2025.100266_bb0040","doi-asserted-by":"crossref","first-page":"1322729","DOI":"10.3389\/fphys.2024.1322729","article-title":"Cell-type specific effects of mineralocorticoid receptor gene expression suggest intercellular communication regulating fibrosis in skeletal muscle disease","volume":"15","author":"Gomatam","year":"2024","journal-title":"Front. Physiol."},{"key":"10.1016\/j.endmts.2025.100266_bb0045","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/j.2040-4603.2014.tb00569.x","article-title":"The multifaceted mineralocorticoid receptor","volume":"4","author":"Gomez-Sanchez","year":"2014","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.endmts.2025.100266_bb0050","first-page":"2030","article-title":"Mineralocorticoid receptor antagonists improve membrane integrity independent of muscle force in muscular dystrophy","volume":"28","author":"Hauck","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.endmts.2025.100266_bb0055","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.ajpath.2021.01.008","article-title":"Early inflammation in muscular dystrophy differs between limb and respiratory muscles and increases with dystrophic severity","volume":"191","author":"Howard","year":"2021","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.endmts.2025.100266_bb0060","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.159875","article-title":"Mineralocorticoid receptor antagonists and glucocorticoids differentially affect skeletal muscle inflammation and pathology in muscular dystrophy","volume":"7","author":"Howard","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.endmts.2025.100266_bb0065","doi-asserted-by":"crossref","first-page":"C354","DOI":"10.1152\/ajpcell.00411.2021","article-title":"Myeloid mineralocorticoid receptors contribute to skeletal muscle repair in muscular dystrophy and acute muscle injury","volume":"322","author":"Howard","year":"2022","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.endmts.2025.100266_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088360","article-title":"Prednisolone attenuates improvement of cardiac and skeletal contractile function and histopathology by lisinopril and spironolactone in the mdx mouse model of Duchenne muscular dystrophy","volume":"9","author":"Janssen","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.endmts.2025.100266_bb0075","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3233\/JND-160173","article-title":"Similar efficacy from specific and non-specific mineralocorticoid receptor antagonist treatment of muscular dystrophy mice","volume":"3","author":"Lowe","year":"2016","journal-title":"J. Neuromusc. Diseases"},{"key":"10.1016\/j.endmts.2025.100266_bb0080","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1002\/ehf2.12996","article-title":"Mineralocorticoid receptor antagonism by finerenone is sufficient to improve function in preclinical muscular dystrophy","volume":"7","author":"Lowe","year":"2020","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.endmts.2025.100266_bb0085","doi-asserted-by":"crossref","first-page":"1287616","DOI":"10.3389\/fphar.2023.1287616","article-title":"Editorial: big data for biomedical research of inflammatory diseases","volume":"14","author":"Mao","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.endmts.2025.100266_bb0090","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1161\/CIRCULATIONAHA.111.031716","article-title":"Early treatment with lisinopril and spironolactone preserves cardiac and skeletal muscle in duchenne muscular dystrophy mice","volume":"124","author":"Rafael-Fortney","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.endmts.2025.100266_bb0095","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1474-4422(14)70318-7","article-title":"Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trial","volume":"14","author":"Raman","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.endmts.2025.100266_bb0100","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13023-017-0590-8","article-title":"Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: results of a two-year open-label extension trial","volume":"12","author":"Raman","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.endmts.2025.100266_bb0105","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013501","article-title":"Stabilization of early Duchenne cardiomyopathy with aldosterone inhibition: results of the multicenter AIDMD trial","volume":"8","author":"Raman","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.endmts.2025.100266_bb0110","doi-asserted-by":"crossref","first-page":"H176","DOI":"10.1152\/ajpheart.00421.2002","article-title":"Aldosterone stimulates proliferation of cardiac fibroblasts by activating Ki-RasA and MAPK1\/2 signaling","volume":"284","author":"Stockand","year":"2003","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.endmts.2025.100266_bb0115","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/j.2040-4603.2018.tb00051.x","article-title":"Immunobiology of inherited muscular dystrophies","volume":"8","author":"Tidball","year":"2018","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.endmts.2025.100266_bb0120","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1172\/JCI41080","article-title":"Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice","volume":"120","author":"Usher","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.endmts.2025.100266_bb0125","doi-asserted-by":"crossref","DOI":"10.1007\/s11255-025-04530-1","article-title":"Mineralocorticoid receptor antagonists promote renal immunosenescence","author":"Wang","year":"2025","journal-title":"Int. Urol. Nephrol."}],"container-title":["Endocrine and Metabolic Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666396125000524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666396125000524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T08:15:40Z","timestamp":1765268140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666396125000524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":25,"alternative-id":["S2666396125000524"],"URL":"https:\/\/doi.org\/10.1016\/j.endmts.2025.100266","relation":{},"ISSN":["2666-3961"],"issn-type":[{"value":"2666-3961","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mineralocorticoid receptor antagonists reduce inflammatory signaling independent of myofiber mineralocorticoid receptor","name":"articletitle","label":"Article Title"},{"value":"Endocrine and Metabolic Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.endmts.2025.100266","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100266"}}